• Composed of a copolymer made from 90% glycolide and 10%-L-lactide
• Predictable breaking strength retention (BSR) profile to provide support for up to 4 weeks while tissues heal
• Synthetic absorbable, size 4-0, undyed braided, 18" (45 cm) suture
• Sterile, factory sealed box of 36 sutures
• Equivalent to Ethicon J392H

Suture Polyglactin is indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic procedures, but not for use in cardiovascular and neurological tissues. In vivo studies demonstrate that VICRYL suture retains approximately 75% of the original tensile strength at 2 weeks post implantation. 

At 3 weeks, approximately 50% of the original strength is retained for sizes 6-0 and larger and approximately 40% of its original strength is retained for sizes 7-0 and smaller. At four weeks, approximately 25% of the original strength is retained for sizes 6-0 and larger. For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.